GreenWay Network

Amigo is a developer of a platform for building, training, and deploying clinical AI agents that enables healthcare organizations to create patient-facing agents for care delivery. The platform provides a unified data foundation for every clinical workflow, offering solutions including proactive outreach, scheduling and reminders, intake and triage, pre-visit preparation, between-visit support, post-visit follow-up, medication management, clinical scribe and copilot, care plan generation, and referral management. Amigo's cognitive architecture supports clinician-led development, simulation-validated evaluations, and real-time monitoring through a process called the Amigo Digital Residency, which trains agents on millions of simulated patient interactions. The platform maintains full HIPAA, SOC 2, and GDPR compliance and natively integrates with major EHRs including Epic, Oracle Cerner, athenahealth, AdvancedMD, eClinicalWorks, and others. Amigo serves specialties spanning primary care, digital health, orthopedics, women's health, behavioral health, and cancer care, and has reached over 10 million patients worldwide with a 100% safety record. Founded in 2023 and headquartered in New York City, Amigo has raised $17.3 million in Series A funding from investors including Madrona, Optum Ventures, General Catalyst, GSV Ventures, SV Angel, and Coho Deeptech.